Hongli Huang

发表

Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view

Huiting Chen, Hongli Huang, Yongqiang Li, 2020, World journal of gastroenterology.

Fecal microbiota transplantation to treat Parkinson's disease with constipation

Y. Nie, Jie He, Huiting Chen, 2019, Medicine.

Influence of polygenetic polymorphisms on the susceptibility to non‐alcoholic fatty liver disease of Chinese people

Y. Nie, Hongli Huang, Yongjian Zhou, 2010, Journal of gastroenterology and hepatology.

Unconjugated Bilirubin Attenuates DSS-Induced Colitis Potentially via Enhancement of Bilirubin Reabsorption

Y. Nie, Yanlei Du, Hongli Huang, 2021, Frontiers in Pharmacology.

Altered Pattern of Immunoglobulin A-Targeted Microbiota in Inflammatory Bowel Disease After Fecal Transplantation

L. Zhang, Hongli Huang, Haoming Xu, 2022, Frontiers in Microbiology.

Fecal Microbiota Transplantation Combined with a Low FODMAP Diet for the Treatment of Irritable Bowel Syndrome with Predominant Diarrhea

Liu Yang, Huiting Chen, Hongli Huang, 2022, Oxidative medicine and cellular longevity.

Inhibition of PD-1 Protects against TNBS-Induced Colitis via Alteration of Enteric Microbiota

Yingfei Li, Y. Nie, Yanlei Du, 2021, BioMed research international.

Genomic insights from Paraclostridium bifermentans HD0315_2: General features and pathogenic potential

Y. Nie, Hongli Huang, Hai-Lan Zhao, 2022, Frontiers in Microbiology.

Inhibiting M1 Macrophage Polarization, Using Small Interfering Forkhead Box Class Family Protein 1 (FOXO1)-Loaded Selenium Nanoparticles, Alleviates Hepatic Steatosis

Huiting Chen, Hongli Huang, Yongqiang Li, 2022, Science of Advanced Materials.

Fecal Microbiota Transplantation: A New Therapeutic Attempt from the Gut to the Brain

Y. Nie, Hongli Huang, Haoming Xu, 2021, Gastroenterology research and practice.

Efficacy and safety of fecal microbiota transplantation for treating patients with ulcerative colitis: A systematic review and meta‐analysis

Y. Nie, Jie He, Hongli Huang, 2020, Journal of digestive diseases.

Prodigiosin impairs autophagosome-lysosome fusion that sensitizes colorectal cancer cells to 5-fluorouracil-induced cell death.

Y. Nie, Yanlei Du, Jie He, 2020, Cancer letters.

Protein expression-based classification of gastric cancer by immunohistochemistry of tissue microarray

D. Zang, Y. Nie, Yanlei Du, 2020, PloS one.

Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders?

Yingfei Li, Y. Nie, Yanlei Du, 2019, BioMed research international.

Association of DCBLD2 upregulation with tumor progression and poor survival in colorectal cancer

Y. Nie, Yanlei Du, Yuyuan Li, 2020, Cellular Oncology.

Down-Regulation of MicroRNA-214 Contributed to the Enhanced Mitochondrial Transcription Factor A and Inhibited Proliferation of Colorectal Cancer Cells

Y. Zhan, Yulong He, Hongli Huang, 2018, Cellular Physiology and Biochemistry.

Association of DCBLD2 upregulation with tumor progression and poor survival in colorectal cancer

Hong Wang, Y. Nie, Yanlei Du, 2020, Cellular Oncology.

Genome insights of Enterococcus raffinosus CX012922, isolated from the feces of a Crohn’s disease patient

Y. Nie, Hongli Huang, Youlian Zhou, 2021, Gut Pathogens.

Intestinal mucosal microbiota composition of patients with acquired immune deficiency syndrome in Guangzhou, China

Yingfei Li, Y. Nie, Jing Xu, 2021, Experimental and therapeutic medicine.

First Application of Fecal Microbiota Transplantation in Adult Asperger Syndrome With Digestive Symptoms—A Case Report

Y. Nie, Huiting Chen, Hongli Huang, 2022, Frontiers in Psychiatry.

Characterization of short-chain fatty acids in patients with ulcerative colitis: a meta-analysis

Y. Nie, Hongli Huang, Haoming Xu, 2022, BMC Gastroenterology.

Yingfei Li, Y. Nie, Hongli Huang, 2017, Oncology letters.

Selection strategy of dextran sulfate sodium-induced acute or chronic colitis mouse models based on gut microbial profile

Y. Nie, Huiting Chen, Hongli Huang, 2021, BMC microbiology.

Microbial Intervention as a Novel Target in Treatment of Non-Alcoholic Fatty Liver Disease Progression

Y. Nie, Jie Cao, Yanlei Du, 2018, Cellular Physiology and Biochemistry.

Fecal microbiota transplantation ameliorates active ulcerative colitis

Y. Nie, Jie He, Huiting Chen, 2020, Experimental and therapeutic medicine.

Dopamine D2 receptor suppresses gastric cancer cell invasion and migration via inhibition of EGFR/AKT/MMP-13 pathway.

Y. Nie, Yanlei Du, Hongli Huang, 2016, International immunopharmacology.

The effect of different combinations of antibiotic cocktails on mice and selection of animal models for further microbiota research

Yanlei Du, Jie He, Hongli Huang, 2021, Applied Microbiology and Biotechnology.

Cross-Talk Between Butyric Acid and Gut Microbiota in Ulcerative Colitis Following Fecal Microbiota Transplantation

Y. Nie, Jie He, Hongli Huang, 2021, Frontiers in Microbiology.

Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota

Y. Nie, Jie He, Huiting Chen, 2019, Journal of digestive diseases.

Low molecular weight heparin synergistically enhances the efficacy of adoptive and anti-PD-1-based immunotherapy by increasing lymphocyte infiltration in colorectal cancer

K. Xie, Jie He, Hongli Huang, 2023, Journal for ImmunoTherapy of Cancer.

Pretreatment with an antibiotics cocktail enhances the protective effect of probiotics by regulating SCFA metabolism and Th1/Th2/Th17 cell immune responses

Jiaqi Wang, Yingfei Li, Hongli Huang, 2024, BMC microbiology.